GBS Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights

- Discussions underway between the University of Newcastle and GBS to oversee the high-tech manufacturing facility supported by its $4.7 Million Grant FundingAward from Australian Government -

Related Keywords

Australia ,California ,United States ,Australian ,American ,Spiro Sakiris ,Tim Mccarthy ,Steven Boyages ,Linkedin ,Twitter ,Company Contact ,Nasdaq ,Key Development ,Clinical Development Plan ,Research Future Fund ,Research Commercialization Initiative ,Lifesci Advisors ,Regulatory Affairs ,Drug Administration ,Researcha Study ,Researchb Study ,Gbs Inc ,Exchange Commission ,Biosensor Algorithm Development ,Securities Exchange ,Peninsula Medical Center ,University Of Newcastle ,Grant Fundingaward ,Australian Government ,Cash Equivalents ,Marketable Securities ,Provides Estimated Runway ,Webcast Today ,Chief Executive Officer ,Medical Research Commercialization Initiative ,Early Stage Translation ,Commercialization Support ,Medical Research Future Fund ,Asian Pacific ,Quality Assurance ,Life Science Biosensor Diagnostics ,Breakthrough Device ,Mills Peninsula Medical Center ,Glucose Tolerance Testing ,Clinical Plan ,Targeted Milestones ,Calendar Year ,Saliva Glucose Biosensor ,Manufacturing Setup Completed ,Clinical Milestone Targets Correlate ,Preliminary Biosensor ,North American ,Webcast Registration Link ,Biosensor Platform ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Managing Director Lifesci Advisors ,Chief Financial Officer ,Money ,Ational ,